The Barcelona Institute for Global Health (ISGlobal) is a cutting-edge institute addressing global public health challenges through research, translation into policy and education. ISGlobal has a broad portfolio in communicable and non-communicable diseases including environmental and climate determinants, and applies a multidisciplinary scientific approach ranging from the molecular to the population level. Research is organized in the following main areas, Malaria and other Infectious Diseases, Maternal, Child and reproductive Health, Urban Health and Child and environmental health, Climate & Non-Communicable Diseases. ISGlobal is accredited with the Severo Ochoa distinction, a seal of excellence of the Spanish Science Ministry.
Barcelona
ISGlobal is seeking an experienced Epidemiologist who is interested in working in the project “MULTIple doses of IPTi, (MULTIPLY)”. MULTIPLY is a multi-country implementation project, which includes public and private European and African institutions aiming at maximising the delivery and uptake of Intermittent Preventive Treatment of malaria in infants (IPTi), to achieve full potential and effectiveness of this intervention. It will be carried out in selected country districts of Mozambique, Sierra Leone and Togo.
The 40 month project, which started in May 2021, is funded by the European and Developing Countries Trial Partnership (EDCTP) and coordinated by ISGlobal, the Barcelona Institute for Global Health, in partnership with the Institut de Recherche pour le Développement (IRD), France, the Fundaçao Manhiça (FM), Mozambique, the University of Lomé (UL), Togo, the University of Sierra Leone, Sierra Leone and the Medicines for Malaria Venture (MMV), Switzerland.
The consortium will work closely with the Ministries of Health in Sierra Leone, Togo and Mozambique, the World Health Organization (WHO) as well as other stakeholders, to ensure that all project outputs are met.
MULTIPLY will generate evidence for change and expand access to preventive chemotherapy for malaria in infants in sub-Saharan Africa applying a community-based approach that fosters partnership and strengthens the dynamic link between communities and health facilities, especially for the most vulnerable people. A learning-driven approach will be employed throughout the project to generate sufficient evidence to inform WHO policy recommendations and future actions in each country, in an effort to expand the intervention over the long-term.
ISGlobal is the lead evaluation and research organization and is responsible for implementing a set of studies to generate evidence for global guidance on IPTi. Specifically, ISGlobal is responsible for designing and implementing the project’s evaluation plan, as well as designing, analysing and reporting the clinical and operational research studies to assess the effectiveness and impact of the intervention, including its feasibility of the intervention through the EPI.
Under the guidance of the MULTIPLY Project Director and Project Manager the candidate will be expected to:
Qualifications:
Experience:
Required competencies:
Desirable:
This vacancy is archived.